Cross Country Healthcare Q4 revenue down 24% YoY, net loss widens.

• Cross Country Healthcare reports Q4 2025 revenue of $236.8mln, down 24% YoY. • Q4 2025 gross profit margin at 20.3%, down 10bps YoY. • Net loss at $82.9mln, a 2.1mln increase YoY. • Diluted EPS at $(2.56), a $2.44 increase YoY. • Adjusted EBITDA at $4.1mln, down 56% YoY. • Adjusted EBITDA margin at 1.7%, down 38bps YoY. • Full year 2025 revenue at $1.05bln, down 22% YoY. • Net loss at $94.9mln, a 0.5mln increase YoY. • Diluted EPS at $(2.93), a $2.49 increase YoY. • Adjusted EBITDA at $26.8mln, down 45% YoY.